Skip to Main Content

Paper Details

A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS.
Sci Rep
9
2022
', ARDS, CD11b, CD11b+, COVID-19, COVID-19-ARDS, DEspR, DEspR ligands, DEspR+, DEspR+ neutrophils, DEspR+CD11b+ neutrophils, DEspR[-] neutrophils, MOF, Neutrophil, RNA, Rhesus, Rhesus-derived DEspR+CD11b+ neutrophils, acute respiratory distress syndrome, anti-DEspR-IgG4 antibody, cancer, dual, dysregulated neutrophil-subset, endothelin-1/VEGF-signal peptide receptor, hu6g8, humanized, monocytes, multi-organ-failure, neutrophil, neutrophils, patients, rogue' neutrophil-subset, scRNA-seq
Author NameAffiliation
Allan J WalkeyBoston University School of Medicine, and Boston Medical Center
Rebecca M BaronBrigham and Women's Hospital, Harvard Medical School
William T KimberlyMassachusetts General Hospital, Harvard Medical School
Joshua N GoldsteinMassachusetts General Hospital, Harvard Medical School
Roland EilsCenter for Digital Health, Berlin Institute of Health and Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin
Roland EilsCenter for Digital Health, Berlin Institute of Health and Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin
  • 1 - 6

Datasets

Release 1.2